F Horodniceanu
About
In The Last Decade
F Horodniceanu
36 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Molecular Biology 659
- Genetics 439
- Epidemiology 354
- Cardiology and Cardiovascular Medicine 302
- Infectious Diseases 265
Countries citing papers authored by F Horodniceanu
This map shows the geographic impact of F Horodniceanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Horodniceanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Horodniceanu more than expected).
Fields of papers citing papers by F Horodniceanu
This network shows the impact of papers produced by F Horodniceanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Horodniceanu. The network helps show where F Horodniceanu may publish in the future.
Co-authorship network of co-authors of F Horodniceanu
This figure shows the co-authorship network connecting the top 25 collaborators of F Horodniceanu. A scholar is included among the top collaborators of F Horodniceanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Horodniceanu. F Horodniceanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 86 | |
| 2 | 70 | |
| 3 | 21 | |
| 4 | 15 | |
| 5 | 3 | |
| 6 | Construction of a dominant selective marker useful for gene transfer studies in animal cells. | 3 |
| 7 | Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies. | 17 |
| 8 | A new dominant hybrid selective marker for higher eukaryotic cells breakdown → | 564 |
| 9 | 3 | |
| 10 | Presence and quantification of cell substrate DNA in inactivated poliovirus vaccine. | 0 |
| 11 | 2 | |
| 12 | 1 | |
| 13 | Purification of poliovirus obtained from human diploid cells by means of DEAE-Sepharose. | 5 |
| 14 | 8 | |
| 15 | The use of inhibitors in the study of picornavirus genetics. | 11 |
| 16 | Distinctive features and comparative value of the genetic markers defining the behaviour of poliovirus towards different selective inhibitors. | 1 |
| 17 | 2 | |
| 18 | 3 | |
| 19 | 5 | |
| 20 | Character of plaque formation by polioviruses in various common cell culture systems. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.